Pifeltro contains doravirine, a new non-nucleoside reverse transcriptase inhibitor, and Delstrigo is a fixed-dose combination of doravirine, lamivudine, and tenofovir disoproxil fumarate.
FDA Approvals …read more
Pifeltro contains doravirine, a new non-nucleoside reverse transcriptase inhibitor, and Delstrigo is a fixed-dose combination of doravirine, lamivudine, and tenofovir disoproxil fumarate.
FDA Approvals …read more
Comments are closed.
Nice posts! 🙂
___
Sanny